News

2015
30 September

Early Access to Medicines Marketing Authorisation Flexibilities Should Only Respond to Unmet Medical Needs, Must Protect Patient Safety
16 September

Direct Patient Reporting in the EU: A Snapshot of Reporting Systems in Seven Member States
18 August

Declaration of Public Interest Regarding Access to Imatinib (Glivec) in Colombia
8 July

Health Action International Opposes European Parliament’s ISDS Compromise in TTIP
7 July

EU Medicines Policy and Access to Medicines
2 July

Health Groups Call on European Medicines Agencies to Address Independence and Transparency Problems
29 June

HAI Sexual Harassment Policy
24 June

We Need a Reponsible R&D Model
23 June

Health Action International Launches New Brussels Office
16 June

Health Action International Criticises JURI Support for EU Trade Secrets Directive Report
15 June

End of Transparency: Paving the way for Trade Secrets in TTIP
14 April

How TTIP Could Damage Access to Affordable Medicines in the European Union
23 March

EU Trade Secrets Directive Threat to Free Speech, Health, Environment and Worker Mobility
15 March

Assessing the Nature, Extent and Impact of Regulation of Medicines Promotion
3 March

2014 Annual Report and Financial Statements
1 March

2014 Annual Report and Financial Statements
1 March

Donors
18 February

EU Clinical Trials Regulation: EMA Steers Away from Transparency by Misinterpreting Exception Provisions
4 February

The EU-US trade deal could leave Europeans sick
16 January

Innovative Global Study Launched to Improve Access to Insulin
1 January

HAI Europe Workplan 2015
2014
22 October

Retention of Medicines Policy in DG Health a Victory for Public Health Advocates
16 October

EMA’s Final Policy on Access to Clinical Data: Proactive Access to Some Data, But Strings Attached
14 October

EU Pharmacovigilance Public Hearings Should Be As Transparent and Independent as in US
29 September

Trading Away Access to Medicines – Revisited
29 September

Europe Seeks to Expand Big Pharma Monopoly at Expense of Poor People, Warn NGOs Ahead of TTIP Talks (2014)
12 September

Public Health in Danger with Move of Pharmaceutical Policy to DG Enterprise and Industry
1 September

Mapping External Reference Pricing Practices for Medicines
15 July

Providing Scientific Advice to Pharma Industry Undermines Independence of Regulatory Authorities
14 July

Investor-State Dispute Settlement in EU-US Trade Deal Risks Access to Affordable Medicines